Mobile Menu
Deals & Transactions

Conyers advises Roivant Sciences Ltd. on its business combination with Montes Archimedes Acquisition Corporation

Conyers advised on the business combination of Roivant Sciences Ltd. with Montes Archimedes Acquisition Corporation (MAAC), a special purchase acquisition company sponsored by Patient Square Capital. Roivant will have an initial market capitalization of around US$7 billion following the combination and a consolidated cash position of approximately US$2.5 billion. In connection with the business combination outstanding shares and warrants of MAAC were exchanged for newly issued Roivant shares and warrants, which began trading on Nasdaq under the ticker symbols “ROIV” and “ROIVW” on 1 October 2021.

Director Neil Henderson and Counsel Robert Alexander of Conyers’ Bermuda office worked alongside Davis Polk on the matter.

 


Neil Henderson
Director

Bermuda   +1 441 298 7846



Accolades
_

"I enjoy working with them - they are very dependable, reliable and responsive."
- Chambers Global